Increased vascular-endothelial growth factor (VEGF) tumor expression and response to epidermal growth factor receptor (EGF-R) inhibitor erlotinib in non-small cell lung cancer (NSCLC).

Wolfgang M Brueckl; Anja Schoeberl; Ralph M Wirtz; Samuel Murray; Eckhart G Hahn; Gunther H Wiest

doi:10.1097/JTO.0b013e3181654423

Increased vascular-endothelial growth factor (VEGF) tumor expression and response to epidermal growth factor receptor (EGF-R) inhibitor erlotinib in non-small cell lung cancer (NSCLC).

Wolfgang M Brueckl^* (Erstautor/-in), Anja Schoeberl, Ralph M Wirtz, Samuel Murray, Eckhart G Hahn, Gunther H Wiest

^*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in Fachzeitschrift › Fallbericht › Begutachtung

5 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	314-316
Fachzeitschrift	JOURNAL OF THORACIC ONCOLOGY
Jahrgang	3
Ausgabenummer	3
DOIs	https://doi.org/10.1097/JTO.0b013e3181654423
Publikationsstatus	Veröffentlicht - 2008

Zugriff auf Dokument

10.1097/JTO.0b013e3181654423

Dieses zitieren

@article{6b84770e6167455dba4c5e61ae6eccf9,

title = "Increased vascular-endothelial growth factor (VEGF) tumor expression and response to epidermal growth factor receptor (EGF-R) inhibitor erlotinib in non-small cell lung cancer (NSCLC).",

keywords = "MUTATIONS, GENE",

author = "Brueckl, \{Wolfgang M\} and Anja Schoeberl and Wirtz, \{Ralph M\} and Samuel Murray and Hahn, \{Eckhart G\} and Wiest, \{Gunther H\}",

year = "2008",

doi = "10.1097/JTO.0b013e3181654423",

language = "English",

volume = "3",

pages = "314--316",

journal = "JOURNAL OF THORACIC ONCOLOGY",

issn = "1556-0864",

number = "3",

}

Increased vascular-endothelial growth factor (VEGF) tumor expression and response to epidermal growth factor receptor (EGF-R) inhibitor erlotinib in non-small cell lung cancer (NSCLC). / Brueckl, Wolfgang M (Erstautor/-in); Schoeberl, Anja; Wirtz, Ralph M et al.
in: JOURNAL OF THORACIC ONCOLOGY, Jahrgang 3, Nr. 3, 2008, S. 314-316.

Publikation: Beitrag in Fachzeitschrift › Fallbericht › Begutachtung

TY - JOUR

T1 - Increased vascular-endothelial growth factor (VEGF) tumor expression and response to epidermal growth factor receptor (EGF-R) inhibitor erlotinib in non-small cell lung cancer (NSCLC).

AU - Brueckl, Wolfgang M

AU - Schoeberl, Anja

AU - Wirtz, Ralph M

AU - Murray, Samuel

AU - Hahn, Eckhart G

AU - Wiest, Gunther H

PY - 2008

Y1 - 2008

KW - MUTATIONS

KW - GENE

U2 - 10.1097/JTO.0b013e3181654423

DO - 10.1097/JTO.0b013e3181654423

M3 - Case report

C2 - 18317076

SN - 1556-0864

VL - 3

SP - 314

EP - 316

JO - JOURNAL OF THORACIC ONCOLOGY

JF - JOURNAL OF THORACIC ONCOLOGY

IS - 3

ER -